| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Seer, Inc. | CHIEF LEGAL OFFICER | Class A Common Stock | 273K | $431K | $1.58 | Feb 22, 2024 | Direct |
| Seer, Inc. | CHIEF LEGAL OFFICER | Employee Stock Option (right to buy) | 140K | Feb 6, 2024 | Direct | ||
| Apimeds Pharmaceuticals US, Inc. | Director | Stock Option (right to buy) | 5.78K | May 16, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| APUS | Apimeds Pharmaceuticals US, Inc. | May 16, 2025 | 1 | $0 | 4 | May 20, 2025 | Director |
| APUS | Apimeds Pharmaceuticals US, Inc. | Mar 4, 2025 | 0 | $0 | 3 | May 8, 2025 | Director |
| SEER | Seer, Inc. | Feb 6, 2024 | 4 | -$20K | 4 | Feb 23, 2024 | CHIEF LEGAL OFFICER |
| SEER | Seer, Inc. | Dec 4, 2023 | 1 | -$13.9K | 4 | Dec 6, 2023 | Chief Legal Officer |
| SEER | Seer, Inc. | Feb 21, 2023 | 1 | -$24.6K | 4 | Feb 22, 2023 | General Counsel and Secretary |
| SEER | Seer, Inc. | Feb 15, 2023 | 2 | $0 | 4 | Feb 17, 2023 | General Counsel and Secretary |
| SEER | Seer, Inc. | Jun 8, 2022 | 1 | -$72.9K | 4 | Jun 10, 2022 | General Counsel and Secretary |
| SEER | Seer, Inc. | Feb 8, 2022 | 2 | $0 | 4 | Feb 10, 2022 | General Counsel and Secretary |